Featured News
Showcasing our technology platforms and scientific advancements
// Aug 12, 2026 | Richard King Mellon Foundation
Richard King Mellon Foundation Commits Up to $25 Million to Launch Rare Ventures ™, a First-of-its-Kind Platform for Accelerating Rare Disease Therapies
// Jul 21, 2026 | IN VIVO
How ElevateBio Is Betting On Every Gene Editing Modality At Once
// Jun 05, 2026 | CYTOTHERAPY
Understanding FDA’s reasons for nonapproval: A systematic review of complete response letters in cell and gene therapy
// May 01, 2026 | Genetic Engineering & Biotechnology News
Gene Editing at Scale: Clinic Seeks Generalizable Therapies
// Mar 12, 2026 | Pharma Manufacturing
ElevateBio BaseCamp Pittsburgh seen as model for US manufacturing
// Feb 27, 2026 | Pittsburgh Business Times
Viewpoint: The U.S. government is betting big on biotech: Is this Pittsburgh’s moment to lead?
// Nov 05, 2025 | Pharma Manufacturing
Well-funded startup ElevateBio looks to attain critical manufacturing mass
With $1.3 billion in funding, the company has established a cGMP manufacturing facility in Waltham, Massachusetts, with a second site under construction in Pittsburgh.
// Oct 07, 2025 | BioSpace
BioSpace Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit
The inaugural 40 Under 40 cohort includes CEOs, leaders who have founded or co-founded their company and executives from a range of disciplines. Winners’ accomplishments include shaping drug development, achieving key FDA milestones and launching a new field of study.
// Aug 14, 2025 | BioPharm
ElevateBio BaseCamp Achieves First Multi-Modality ICMC Certification in Commercial CGT Manufacturing
ElevateBio's BaseCamp facility achieved ICMC certification for multi-modal manufacturing capabilities, marking a first in genetic medicines manufacturing.
// Jun 12, 2025 | CNBC
CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatments
ElevateBio CEO Ger Brophy joins ‘Worldwide Exchange’ as ElevateBio ranks #43 on the Disruptor 50 list.
// Mar 11, 2025 | Drug Target Review
AWS and ElevateBio join forces to advance gene editing
ElevateBio is teaming up with Amazon Web Services (AWS) to advance CRISPR gene editing using AI and cloud computing. This collaboration aims to accelerate drug discovery for genetic diseases, making next-generation therapies more efficient and accessible.
// May 23, 2024 | Cell and Gene Therapy
Outsourced Pharma Capacity Update May 2024
Debaditya Bhattacharya, Ph.D. VP, Analytical Development and Miranda Williams Scientist I, Analytical Development discuss BaseCamp’s analytical capabilities and more in a recorded webcast.
